DocuSign (NASDAQ: DOCU) CEO discloses Rule 10b5-1 stock sales by plan

Rhea-AI Filing Summary

DocuSign, Inc. President and CEO Allan C. Thygesen reported planned sales of company common stock. On January 9, 2026, he completed three open-market sales under a Rule 10b5-1 trading plan. The reported transactions were sales of 16,151 shares at $69.35, 9,799 shares at $69.98, and 300 shares at $70.83 per share. Footnotes note that the shares in each trade were sold within stated price ranges and that full price breakdowns are available on request. Following these sales, Thygesen directly beneficially owned 142,261 shares of DocuSign common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thygesen Allan C.

(Last) (First) (Middle)

C/O DOCUSIGN, INC.

221 MAIN STREET, SUITE 800

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		S		16,151(1)	D	$69.35(2)	152,360	D
Common Stock	01/09/2026		S		9,799(1)	D	$69.98(3)	142,561	D
Common Stock	01/09/2026		S		300(1)	D	$70.83(4)	142,261	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.

2. The shares were sold at prices ranging from $68.77 to $69.76. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

3. The shares were sold at prices ranging from $69.77 to $70.71. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

4. The shares were sold at prices ranging from $70.77 to $70.93. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did DocuSign (DOCU) report for Allan C. Thygesen?

DocuSign reported that Allan C. Thygesen, its President and CEO, sold shares of DocuSign common stock in three open-market transactions on January 9, 2026, and filed a Form 4 to disclose these trades.

How many DocuSign (DOCU) shares did the CEO sell and at what prices?

On January 9, 2026, Allan C. Thygesen sold 16,151 shares at $69.35, 9,799 shares at $69.98, and 300 shares at $70.83 per share. Footnotes state that each sale occurred within specified price ranges.

Is the DocuSign CEO’s stock sale linked to a Rule 10b5-1 trading plan?

Yes. A footnote explains that the transactions were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person, indicating the trades were pre-arranged under that plan.

How many DocuSign (DOCU) shares does Allan C. Thygesen still own after these sales?

After the reported transactions, Allan C. Thygesen beneficially owned 142,261 shares of DocuSign common stock in direct ownership.

What price ranges applied to the DocuSign CEO’s stock sales on January 9, 2026?

Footnotes state that shares were sold in ranges of $68.77 to $69.76, $69.77 to $70.71, and $70.77 to $70.93. Detailed breakdowns by price are available from the reporting person on request.

What is the role of Allan C. Thygesen at DocuSign (DOCU)?

Allan C. Thygesen is identified in the filing as both a Director and an Officer of DocuSign, serving as President and CEO.